Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice

Bone

Volumn 60, Issue , 2014, Pages 68-77

  Kondoh, Shino ^a   Inoue, Kazuki ^a,b,c   Igarashi, Katsuhide ^d   Sugizaki, Hiroe ^a   Shirode Fukuda, Yuko ^a   Inoue, Erina ^a   Yu, Taiyong ^a,b   Takeuchi, Jun K ^a,e   Kanno, Jun ^d   Bonewald, Lynda F ^f   Imai, Yuuki ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EHIME UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Bone formation; Estrogen; Estrogen receptor ; Osteocyte; Wnt signaling

Indexed keywords

CATENIN; DENTIN MATRIX PROTEIN 1; ESTROGEN RECEPTOR ALPHA; RNA; STEROID HORMONE; WNT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BONE METABOLISM; BONE MINERALIZATION; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; GENETIC ANALYSIS; HINDLIMB; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCYTE; OSTEOLYSIS; RNA EXTRACTION; TRABECULAR BONE; WNT SIGNALING PATHWAY;

BONE FORMATION; ESTROGEN; ESTROGEN RECEPTOR Α; OSTEOCYTE; WNT SIGNALING;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE TARGETING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; OSTEOBLASTS; OSTEOCYTES; OSTEOGENESIS; PHENOTYPE; WEIGHT-BEARING; X-RAY MICROTOMOGRAPHY;

EID: 84891126649     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.12.005     Document Type: Article

References (65)

1. Nelson H.D. Menopause. Lancet 2008, 371:760-770.
2. Imai Y., Kondoh S., Kouzmenko A., Kato S. Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha. Mol Endocrinol 2010, 24:877-885.
3. Sun L., Peng Y., Sharrow A.C., Iqbal J., Zhang Z., Papachristou D.J., et al. FSH directly regulates bone mass. Cell 2006, 125:247-260.
4. Pacifici R. Estrogen deficiency, T cells and bone loss. Cell Immunol 2008, 252:68-80.
5. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000, 127:4277-4291.
6. Windahl S.H., Andersson G., Gustafsson J.A. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab 2002, 13:195-200.
7. Sims N.A., Dupont S., Krust A., Clement-Lacroix P., Minet D., Resche-Rigon M., et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 2002, 30:18-25.
8. Nakamura T., Imai Y., Matsumoto T., Sato S., Takeuchi K., Igarashi K., et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007, 130:811-823.
9. Martin-Millan M., Almeida M., Ambrogini E., Han L., Zhao H., Weinstein R.S., et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 2010, 24:323-334.
10. Tomkinson A., Reeve J., Shaw R.W., Noble B.S. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 1997, 82:3128-3135.
11. Lee K., Jessop H., Suswillo R., Zaman G., Lanyon L. Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 2003, 424:389.
12. Maatta J.A., Buki K.G., Gu G., Alanne M.H., Vaaraniemi J., Liljenback H., et al. Inactivation of estrogen receptor alpha in bone-forming cells induces bone loss in female mice. FASEB J 2012, 27:478-488.
13. Windahl S.H., Borjesson A.E., Farman H.H., Engdahl C., Moverare-Skrtic S., Sjogren K., et al. Estrogen receptor-alpha in osteocytes is important for trabecular bone formation in male mice. Proc Natl Acad Sci U S A 2013, 110:2294-2299.
14. Almeida M., Iyer S., Martin-Millan M., Bartell S.M., Han L., Ambrogini E., et al. Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest 2013, 123:394-404.
15. Melville K.M., Kelly N.H., Khan S.A., Schimenti J.C., Ross F.P., Main R.P., et al. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength. J Bone Miner Res 2013, (in press) (Epub ahead of print).
16. Burger E.H., Klein-Nulend J. Mechanotransduction in bone-role of the lacuno-canalicular network. FASEB J 1999, (13 Suppl.):S101-S112.
17. Robling A.G., Niziolek P.J., Baldridge L.A., Condon K.W., Allen M.R., Alam I., et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 2008, 283:5866-5875.
18. Skerry T.M., Bitensky L., Chayen J., Lanyon L.E. Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J Bone Miner Res 1989, 4:783-788.
19. Gluhak-Heinrich J., Ye L., Bonewald L.F., Feng J.Q., MacDougall M., Harris S.E., et al. Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res 2003, 18:807-817.
20. Gluhak-Heinrich J., Pavlin D., Yang W., MacDougall M., Harris S.E. MEPE expression in osteocytes during orthodontic tooth movement. Arch Oral Biol 2007, 52:684-690.
21. Thompson D.L., Sabbagh Y., Tenenhouse H.S., Roche P.C., Drezner M.K., Salisbury J.L., et al. Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res 2002, 17:311-320.
22. Nampei A., Hashimoto J., Hayashida K., Tsuboi H., Shi K., Tsuji I., et al. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. J Bone Miner Metab 2004, 22:176-184.
23. Liu S., Zhou J., Tang W., Jiang X., Rowe D.W., Quarles L.D. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 2006, 291:E38-E49.
24. Feng J.Q., Ward L.M., Liu S., Lu Y., Xie Y., Yuan B., et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006, 38:1310-1315.
25. Bonewald L.F. Osteocytes as dynamic multifunctional cells. Ann N Y Acad Sci 2007, 1116:281-290.
26. Bergmann P., Body J.J., Boonen S., Boutsen Y., Devogelaer J.P., Goemaere S., et al. Loading and skeletal development and maintenance. J Osteoporos 2010, 2011:786752.
27. Lloyd S.A., Bandstra E.R., Willey J.S., Riffle S.E., Tirado-Lee L., Nelson G.A., et al. Effect of proton irradiation followed by hindlimb unloading on bone in mature mice: a model of long-duration spaceflight. Bone 2012, 51:756-764.
28. Lee K.C., Maxwell A., Lanyon L.E. Validation of a technique for studying functional adaptation of the mouse ulna in response to mechanical loading. Bone 2002, 31:407-412.
29. Bonewald L.F., Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 2008, 42:606-615.
30. Robinson J.A., Chatterjee-Kishore M., Yaworsky P.J., Cullen D.M., Zhao W., Li C., et al. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 2006, 281:31720-31728.
31. Javaheri B., Stern A., Lara N., Dallas M., Zhao H., Liu Y., et al. Deletion of a single beta-catenin allele in osteocytes abolishes the bone anabolic response to loading. J Bone Miner Res 2013, (in press) (Epub ahead of print).
32. Armstrong V.J., Muzylak M., Sunters A., Zaman G., Saxon L.K., Price J.S., et al. Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J Biol Chem 2007, 282:20715-20727.
33. Lu Y., Xie Y., Zhang S., Dusevich V., Bonewald L.F., Feng J.Q. DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res 2007, 86:320-325.
34. Kalajzic I., Braut A., Guo D., Jiang X., Kronenberg M.S., Mina M., et al. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 2004, 35:74-82.
35. Bouxsein M.L., Boyd S.K., Christiansen B.A., Guldberg R.E., Jepsen K.J., Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010, 25:1468-1486.
36. Sato S., Hanada R., Kimura A., Abe T., Matsumoto T., Iwasaki M., et al. Central control of bone remodeling by neuromedin U. Nat Med 2007, 13:1234-1240.
37. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
38. Paic F., Igwe J.C., Nori R., Kronenberg M.S., Franceschetti T., Harrington P., et al. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 2009, 45:682-692.
39. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
40. McCarthy J.J., Fox A.M., Tsika G.L., Gao L., Tsika R.W. Beta-MHC transgene expression in suspended and mechanically overloaded/suspended soleus muscle of transgenic mice. Am J Physiol 1997, 272:R1552-R1561.
41. Tsika G., Ji J., Tsika R. Sp3 proteins negatively regulate beta myosin heavy chain gene expression during skeletal muscle inactivity. Mol Cell Biol 2004, 24:10777-10791.
42. Xiong J., Onal M., Jilka R.L., Weinstein R.S., Manolagas S.C., O'Brien C.A. Matrix-embedded cells control osteoclast formation. Nat Med 2011, 17:1235-1241.
43. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 2000, 97:12729-12734.
44. Neunaber C., Catala-Lehnen P., Beil F.T., Marshall R.P., Kanbach V., Baranowsky A., et al. Increased trabecular bone formation in mice lacking the growth factor midkine. J Bone Miner Res 2010, 25:1724-1735.
45. Ahn Y., Sanderson B.W., Klein O.D., Krumlauf R. Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning. Development 2010, 137:3221-3231.
46. He J.W., Yue H., Hu W.W., Hu Y.Q., Zhang Z.L. Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men. J Bone Miner Metab 2011, 29:571-581.
47. Tou J.C., Foley A., Yuan Y.V., Arnaud S., Wade C.E., Brown M. The effect of ovariectomy combined with hindlimb unloading and reloading on the long bones of mature Sprague-Dawley rats. Menopause 2008, 15:494-502.
48. Almeida M., Martin-Millan M., Ambrogini E., Bradsher R., Han L., Chen X.D., et al. Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERalpha. J Bone Miner Res 2010, 25:769-781.
49. Tomkinson A., Gevers E.F., Wit J.M., Reeve J., Noble B.S. The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 1998, 13:1243-1250.
50. Krum S.A., Miranda-Carboni G.A., Hauschka P.V., Carroll J.S., Lane T.F., Freedman L.P., et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J 2008, 27:535-545.
51. Kawano H., Sato T., Yamada T., Matsumoto T., Sekine K., Watanabe T., et al. Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci U S A 2003, 100:9416-9421.
52. Sinnesael M., Claessens F., Laurent M., Dubois V., Boonen S., Deboel L., et al. Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes. J Bone Miner Res 2012, 27:2535-2543.
53. Antonson P., Omoto Y., Humire P., Gustafsson J.A. Generation of ERalpha-floxed and knockout mice using the Cre/LoxP system. Biochem Biophys Res Commun 2012, 424:710-716.
54. Cho S.W., Kwak S., Woolley T.E., Lee M.J., Kim E.J., Baker R.E., et al. Interactions between Shh, Sostdc1 and Wnt signaling and a new feedback loop for spatial patterning of the teeth. Development 2011, 138:1807-1816.
55. Itasaki N., Jones C.M., Mercurio S., Rowe A., Domingos P.M., Smith J.C., et al. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 2003, 130:4295-4305.
56. Liu G., Vijayakumar S., Grumolato L., Arroyave R., Qiao H., Akiri G., et al. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol 2009, 185:67-75.
57. Takada I., Kouzmenko A.P., Kato S. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 2009, 5:442-447.
58. Augello A., De Bari C. The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther 2010, 21:1226-1238.
59. Baron R., Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 2013, 19:179-192.
60. Westendorf J.J., Kahler R.A., Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39.
61. Kouzmenko A.P., Takeyama K., Ito S., Furutani T., Sawatsubashi S., Maki A., et al. Wnt/beta-catenin and estrogen signaling converge in vivo. J Biol Chem 2004, 279:40255-40258.
62. Tee M.K., Rogatsky I., Tzagarakis-Foster C., Cvoro A., An J., Christy R.J., et al. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell 2004, 15:1262-1272.
63. Nakamura E., Kadomatsu K., Yuasa S., Muramatsu H., Mamiya T., Nabeshima T., et al. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells 1998, 3:811-822.
64. Liedert A., Mattausch L., Rontgen V., Blakytny R., Vogele D., Pahl M., et al. Midkine-deficiency increases the anabolic response of cortical bone to mechanical loading. Bone 2011, 48:945-951.
65. Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.